
Blowing into a shell can stop you snoring
The practice of conch blowing, also known as shankh blowing, could increase oxygen levels and improve sleep for patients with obstructive sleep apnoea (OSA) without the need for a machine, according to researchers.
Shankh blowing involves breathing in deeply before exhaling forcefully into a conch, the spiral-shaped shell from a species of sea snail.
The experts found that regular use helped improved participants' symptoms, potentially because it strengthened the muscles in the throat and airway that are prone to collapse during sleep.
OSA is a condition that causes the walls of the throat to temporarily relax during sleep, narrowing or closing the airway, and stopping the person from breathing.
As a result, symptoms include snoring, loud inhales or choking sounds, waking up a lot, as well as sleepiness during the day and brain fog as a result of oxygen supply to the brain being disrupted.
About eight million people are thought to have the condition in the UK but fewer than one in five have been diagnosed.
The small trial, led by researchers in India, involved 30 people aged 19 to 65 with OSA. They were split into groups, with half given a traditional shankh used in yoga and trained on how to use it before taking it home, while the other half were asked to carry out deep breathing exercises.
Both groups were encouraged to practice for a minimum of 15 minutes five days a week. They were monitored during sleep and asked questions about sleep quality and how tired they felt during the day.
Higher blood oxygen levels
After six months, the study found that those blowing into the conch shell were sleeping better and 34 per cent less sleepy during the day. They also had higher levels of oxygen in the blood during the night and had four to five fewer apnoea episodes, where breathing stops during sleep, per hour on average.
Dr Krishna K Sharma, of the Eternal Heart Care Centre and Research Institute in Jaipur, India, said: 'The way the shankh is blown is quite distinctive. It involves a deep inhalation followed by a forceful, sustained exhalation through tightly pursed lips.
'[It] creates strong vibrations and airflow resistance, which likely strengthens the muscles of the upper airway, including the throat and soft palate, areas that often collapse during sleep in people with OSA.'
Dr Sharma added: 'The shankh's unique spiralling structure may also contribute to specific acoustic and mechanical effects that further stimulate and tone these muscles.'
Continuous positive airway pressure (Cpap) machines are the usual treatment for OSA, and involve wearing a mask that blows pressurised air into the nose and throat during sleep, but many people find them uncomfortable.
'Promising alternative'
Dr Sharma said people also 'struggle to use it consistently' and so blowing into these could be a 'promising alternative'.
He said: 'Shankh blowing is a simple low-cost, breathing technique that could help improve sleep and reduce symptoms without the need for machines or medication.'
Researchers are now planning a larger trial involving several hospitals.
Responding to the study, Prof Sophia Schiza, the head of the ERS group on sleep disordered breathing, based at the University of Crete, said: 'While Cpap and other treatments are available based on careful diagnosis of disease severity, there is still need for new treatments.
'This is an intriguing study that shows the ancient practice of shankh blowing could potentially offer an OSA treatment for selected patients by targeting muscles training. A larger study will help provide more evidence for this intervention.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Independent
6 minutes ago
- The Independent
Blowing through conch shell could help treat dangerous sleep condition
Blowing a conch shell regularly could help reduce the symptoms of a dangerous sleep condition, according to new research. Shankh blowing is an ancient Indian practice used by yogis for thousands of years, and involves deep inhalation followed by forceful exhalation through a conch shell. But scientists now believe the technique could have huge benefits for those suffering from obstructive sleep apnoea (OSA) - a relatively common condition where airways become blocked at night, interrupting peaceful breathing. A study published in ERJ Open Research on Monday shows that people with moderate OSA who practised shankh blowing slept better, felt more alert during the day and had fewer breathing interruptions at night. Researchers are now arguing the ancient method could be a simple and cheap way to reduce symptoms without the need for medication or machines. Around 1.5 million adults in the UK are estimated to have OSA. As well as loud snoring and daytime sleepiness, the condition can also increase the risk of serious health issues such as high blood pressure, heart disease, and strokes. In the study, a group of 30 people with moderate OSA were randomly assigned either shankh blowing or deep breathing exercises, which each group encouraged to practice at least 15 minutes per day for five days a week. Researchers said when the groups were reassessed six months later, the people who practised shankh blowing were 34 per cent less sleepy during the daytime. The study found they also reported sleeping better, and monitoring of their sleep revealed that they had four to five fewer apnoeas (where breathing stops during sleep) per hour on average. They also had higher levels of oxygen in their blood during the night. The study was led by Dr Krishna K Sharma from the Eternal Heart Care Centre and Research Institute in Jaipur, India. He said their research showed potential for an alternative to the current treatment of a continuous positive airway pressure machine, or CPAP, which patients can find 'uncomfortable'. Dr Sharma said: 'The way the shankh is blown is quite distinctive. It involves a deep inhalation followed by a forceful, sustained exhalation through tightly pursed lips. This action creates strong vibrations and airflow resistance, which likely strengthens the muscles of the upper airway, including the throat and soft palate – areas that often collapse during sleep in people with OSA. The shankh's unique spiralling structure may also contribute to specific acoustic and mechanical effects that further stimulate and tone these muscles. 'For people living with OSA, especially those who find CPAP uncomfortable, unaffordable, or inaccessible, our findings offer a promising alternative. Shankh blowing is a simple low-cost, breathing technique that could help improve sleep and reduce symptoms without the need for machines or medication. He added the study was 'small', but researchers are now planning a larger trial involving several hospitals.


Daily Mail
7 minutes ago
- Daily Mail
People who live to 100 all share a 'superhuman' ability, scientists discover... could YOU be one of them?
People who live to 100 appear to have a 'superhuman' ability to avoid major illnesses, according to new research. Two large studies of older adults in Sweden have found that centenarians tend to develop fewer diseases, accumulate them more slowly, and in many cases avoid the most deadly age-related conditions altogether—despite living far longer than their peers. The work, published by an international research team, suggests that exceptional longevity is linked to a distinct pattern of ageing in which illness is delayed or even avoided entirely. The findings challenge the widely held belief that a longer life inevitably comes with more years of poor health. Researchers analysed decades of health records to compare people who reached 100 with those who died earlier but were born in the same years. They looked at the timing and number of diagnoses for a wide range of conditions— from strokes and heart attacks to cancers and neuropsychiatric diseases—to see whether centenarians were simply better at surviving disease, or whether they avoided it altogether. The first study examined health records for 170,787 people born in Stockholm County between 1912 and 1922. Participants were tracked for up to 40 years—either from the age of 60 until death, or until they turned 100. The analysis showed that centenarians not only had lower rates of disease in late-midlife, they maintained this advantage throughout their lives. For example, at the age of 85, only four per cent of those who went on to live to 100 had experienced a stroke. Among those who died between the ages of 90 and 99, the figure was around 10 per cent. Similarly, by the age of 100, just 12.5 per cent of centenarians had experienced a heart attack, compared to more than 24 per cent of those who died in their 80s. Researchers say this suggests they are not merely surviving serious illness better than others—they are avoiding it for much longer, and sometimes altogether. However, the first study focused on more serious diagnoses of major diseases. To investigate whether the key to longevity might also lie in avoiding less severe conditions, the team conducted a second study. This analysis included 40 different medical conditions, ranging from mild to severe, such as hypertension, heart failure, diabetes and heart attacks. Researchers examined records for 274,108 people born between 1920 and 1922 and followed them for around 30 years—either from age 70 until death, or until they turned 100. Only 4,330 participants – 1.5 per cent—reached the age of 100. Even when including a wider range of conditions, the findings were consistent: centenarians developed fewer diseases overall, and their rate of disease accumulation was slower across their lifetime. Cardiovascular disease was the most common diagnosis across all age groups, but it was significantly less prevalent among centenarians. At age 80, only 8 per cent had been diagnosed with cardiovascular disease, compared to more than 15 per cent of those who died at 85. The lower rates of cardiovascular illness appeared central to their extended survival. Centenarians also demonstrated greater resilience to neuropsychiatric conditions such as depression and dementia throughout life. While most centenarians did eventually develop multiple health conditions, this usually occurred much later in life—around the age of 89—and without the sharp health decline seen in non-centenarians during their final years. By contrast, non-centenarians typically experienced a steep increase in the number of health problems in the last years of their lives. This pattern was not observed in those who reached 100, whose health decline was slower and more gradual, even into their 90s. Professor Karin Modig, an expert in diseases who led the study, said: 'The finding that centenarians manage to delay, and in some cases, avoid disease despite living longer is both intriguing and encouraging. 'It show it's possible to age more slowly than is typical—and challenges the common belief that a longer life inevitably comes with more disease.' The reasons for this resilience remain unclear. It could be due to genetic advantages, healthy lifestyle habits, environmental factors—or a combination of all three. The team now plans to investigate which factors are most important, and how they influence health throughout life. The oldest living person in the world is now believed to be Brazilian nun Inah Canabarro Lucas, who was born on June 8, 1908 and is 116 years old. At the age of 115, Ethel Caterham, from Surrey, is the oldest living person in the UK following the death of 112-year-old Mollie Walker on 22 January 2022. Ms Caterham, who died in 1997, attributed her longevity to 'never arguing with anyone, I listen and I do what I like'.


The Sun
37 minutes ago
- The Sun
Painkiller taken by millions could trigger deadly heart failure – are you in the at-risk groups?
A POPULAR medication used to treat chronic nerve pain, anxiety and epilepsy has been linked to a significantly increased risk of heart failure. Doctors have been urged to exercise caution when prescribing the medicine to certain people. Pregabalin, which is available on prescription in the UK, was associated with a 48 per cent increased risk of developing heart failure, according to the findings of a major new study. For those with a history of heart disease, the risk was found to be even greater. Researchers found in these patients, the risk of heart failure soared to 85 per cent, compared to those prescribed gabapentin - a similar drug taken for nerve pain. Pregabalin is commonly used to treat nerve pain, as this type of pain is often not relieved by traditional painkillers. It treats pain by changing the way in which nerves send messages to your brain. While pregabalin is considered safe to take under medical supervision, like all medicines, it can cause side effects, including headaches, diarrhoea, feeling sick, blurred vision, and memory problems. In rare cases it can trigger a serious allergic reaction known as anaphylaxis. Now, researchers at Columbia University Irving Medical Centre are calling for doctors to carefully consider the cardiovascular risks when prescribing it to older or vulnerable patients. In their new study, they analysed data from 246,237 Medicare patients aged 65 to 89 over a four-year period. The sleep position that could be a sign of heart failure - plus three other symptoms to look out for Everyone had chronic non- cancer pain - pain lasting more than 12 weeks or beyond the normal healing time - and none had a previous history of heart failure. Heart failure is a condition where the heart can't pump enough blood to meet the body's needs. While it can occur at any age, the risk significantly increases with age due to the natural weakening and stiffening of the heart muscle. During the four-year study period, 1,470 patients were admitted to hospital with heart failure. The researchers found for every 1,000 people taking pregabalin, there were around six additional cases of heart failure each year, compared to those who didn't take the drug. After adjusting for potential variables, including age and pre-existing health issues, they concluded patients taking pregabalin are 1.5 times more likely to suffer heart failure. 2 The research team, led by Dr Elizabeth Park, concluded their findings support current advice from the European Medicines Agency to exercise caution when prescribing pregabalin to older adults with heart disease. There isn't a cure for heart failure, but spotting symptoms as early as possible can help manage symptoms before the condition progresses. Heart failure symptoms can include shortness of breath, especially with activity or when lying down, fatigue, and swelling in the legs, ankles, and feet. Other symptoms may include a persistent cough, rapid or irregular heartbeat, dizziness, and feeling lightheaded or fainting. Preventing heart failure in the first place is also important. This includes maintaining a healthy weight, being physically active, eating a balanced diet, not smoking, and managing conditions like high blood pressure, high cholesterol, and diabetes.